This suggestive VEGF-A increase in children without ADHD medication was, however, probably driven by a VEGF-A reduction in the placebo group (p = 0.21, n = 7, Figure S5B). The gene discussed is VEGFA; the disease is attention deficit-hyperactivity disorder.